We are live on ! Find out more
LWCFA

Loring Wolcott & Coolidge Fiduciary Advisors Portfolio holdings

AUM $10.3B
1-Year Est. Return 3.26%
This Fund
S&P 500
This Quarter Est. Return
-2.04%
1 Year Est. Return
+3.26%
3 Year Est. Return
+43.63%
5 Year Est. Return
+56.22%
10 Year Est. Return
+342.64%
AUM
$10.3B
AUM Growth
-$1.35B
Cap. Flow
-$95.9M
Cap. Flow %
-0.93%
Top 10 Hldgs %
47.3%
Holding
587
New
27
Increased
58
Reduced
187
Closed
27

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$26.5M
2
SNPS icon
Synopsys
SNPS
+$14.3M
3
PH icon
Parker-Hannifin
PH
+$13.1M
4
DKS icon
Dick's Sporting Goods
DKS
+$12.4M
5
VEEV icon
Veeva Systems
VEEV
+$10.4M

Top Sells

Rank Stock Value
1
WEX icon
WEX
WEX
+$14.8M
2
FISV
Fiserv Inc
FISV
+$11.6M
3
MA icon
Mastercard
MA
+$11.3M
4
PYPL icon
PayPal
PYPL
+$8.43M
5
TJX icon
TJX Companies
TJX
+$7.88M

Sector Composition

Rank Sector Weight
1 Technology 38.85%
2 Healthcare 15.75%
3 Financials 11.64%
4 Consumer Discretionary 10.93%
5 Communication Services 6.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BAM icon
501
Brookfield Asset Management
BAM
$87.1B
$6.27K ﹤0.01%
+124
New +$6.76K
TT icon
502
Trane Technologies
TT
$105B
$5.71K ﹤0.01%
17
CC icon
503
Chemours
CC
$2.29B
$5.44K ﹤0.01%
460
ZION icon
504
Zions Bancorporation
ZION
$10.5B
$5.32K ﹤0.01%
120
NOK icon
505
Nokia
NOK
$57.6B
$5.31K ﹤0.01%
1,000
HXL icon
506
Hexcel
HXL
$7.74B
$4.95K ﹤0.01%
100
MRNA icon
507
Moderna
MRNA
$25.4B
$4.64K ﹤0.01%
175
KHC icon
508
Kraft Heinz
KHC
$29.1B
$4.51K ﹤0.01%
150
COGT icon
509
Cogent Biosciences
COGT
$6.76B
$4.47K ﹤0.01%
1,000
SPMD icon
510
State Street SPDR Portfolio S&P 400 Mid Cap ETF
SPMD
$19B
$4.39K ﹤0.01%
90
NVAX icon
511
Novavax
NVAX
$1.31B
$4.26K ﹤0.01%
570
STK
512
Columbia Seligman Premium Technology Growth Fund
STK
$940M
$4.05K ﹤0.01%
+154
New +$4.84K
SPSM icon
513
State Street SPDR Portfolio S&P 600 Small Cap ETF
SPSM
$17.5B
$4.01K ﹤0.01%
105
RMD icon
514
ResMed
RMD
$32.8B
$3.65K ﹤0.01%
17
QQQX icon
515
Nuveen NASDAQ 100 Dynamic Overwrite Fund
QQQX
$1.51B
$3.43K ﹤0.01%
+150
New +$3.92K
SNAP icon
516
Snap
SNAP
$8.79B
$3.19K ﹤0.01%
400
NAK
517
Northern Dynasty Minerals
NAK
$953M
$3.15K ﹤0.01%
3,000
EMBC icon
518
Embecta
EMBC
$269M
$2.15K ﹤0.01%
191
GEVO icon
519
Gevo
GEVO
$391M
$2.1K ﹤0.01%
+1,814
New +$3.04K
ARCC icon
520
Ares Capital
ARCC
$14.3B
$2.08K ﹤0.01%
+100
New +$2.27K
MET icon
521
MetLife
MET
$61.4B
$1.93K ﹤0.01%
+26
New +$2.16K
CME icon
522
CME Group
CME
$94.3B
$1.83K ﹤0.01%
7
EA
523
DELISTED
Electronic Arts
EA
$1.73K ﹤0.01%
12
GRAL
524
GRAIL Inc
GRAL
$3.08B
$1.38K ﹤0.01%
41
-30
-42% -$927
BYND icon
525
Beyond Meat
BYND
$214M
$1.37K ﹤0.01%
530

Similar funds

Loring Wolcott & Coolidge Fiduciary Advisors's Q1 2025 Portfolio in Review

As of Q1 2025, Loring Wolcott & Coolidge Fiduciary Advisors held 587 positions worth $10.3B, down 12% from $11.6B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Loring Wolcott & Coolidge Fiduciary Advisors's Q1 2025 filing shows 27 new, 58 increased, 187 reduced and 27 closed positions. Its largest new stake was iShares 1-3 Year Treasury Bond ETF: 7,000 shares worth $579K. The largest sale was WEX, an estimated $14.8M.

By sector, the portfolio is most concentrated in Technology at 39% of assets, up from 39% a quarter earlier, followed by Healthcare and Financials.

  • Loring Wolcott & Coolidge Fiduciary Advisors's largest Q1 2025 buy was iShares 1-3 Year Treasury Bond ETF: 7,000 shares worth $579K.
  • Loring Wolcott & Coolidge Fiduciary Advisors added most to NVIDIA in Q1 2025, an estimated $26.5M increase.
  • Loring Wolcott & Coolidge Fiduciary Advisors's biggest Q1 2025 reduction was WEX, cutting an estimated $14.8M.
  • Loring Wolcott & Coolidge Fiduciary Advisors fully exited Universal Health Services in Q1 2025, selling an estimated $3.82M.
  • Loring Wolcott & Coolidge Fiduciary Advisors's ten largest holdings make up 47% of its $10.3B portfolio in Q1 2025.
  • Loring Wolcott & Coolidge Fiduciary Advisors opened 27 new positions and closed 27 in Q1 2025.
  • Loring Wolcott & Coolidge Fiduciary Advisors's portfolio value fell 12% quarter-over-quarter to $10.3B.

Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q1 2025, filed 24 Apr 2025.